Fund shareholders of Oramed Pharmaceuticals Inc
ISIN US68403P2039 · United States · LEI 5299006K52ZIIGQJ6R84
- Fund shareholders
- 19
- Of which ETFs
- 8 11 other funds
- Value held
- 1.1M $
- Share of capital
- 0.7 % of 41.6M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 82,596 | 280.8K $ | 0.02 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 36,536 | 141.8K $ | 0.00 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Nationwide Bailard Small Cap Value Fund Nationwide Mutual Funds | 32,478 | 126K $ | 0.10 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 26,896 | 104.4K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 24,282 | 82.9K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 23,349 | 90.6K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 20,632 | 80.1K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 17,941 | 61.3K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 10,581 | 41.1K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 6,084 | 20.7K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 4,929 | 19.1K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 4,523 | 17.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 4,152 | 14.2K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 3,511 | 13.6K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 3,431 | 13.3K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 3,131 | 12.1K $ | 0.01 % | as of Apr 30, 2026 ↗ | |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,680 | 9.1K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 2,100 | 7.1K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 4 | 15.5 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Nationwide Bailard Small Cap Value Fund Nationwide Mutual Funds | 0.10 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 19 | +2 | 309,836 | +25.2 % |
| 2026Q1 | 17 | 0 | 247,457 | +7.1 % |
| 2025Q4 | 17 | -3 | 230,994 | -37.1 % |
| 2025Q3 | 20 | +1 | 367,525 | -8.4 % |
| 2025Q2 | 19 | 0 | 401,369 | +3.3 % |
| 2025Q1 | 19 | +1 | 388,414 | +38.7 % |
| 2024Q4 | 18 | +4 | 279,951 | +26.9 % |
| 2024Q3 | 14 | 0 | 220,549 | -1.0 % |
| 2024Q2 | 14 | +3 | 222,845 | +8.2 % |
| 2024Q1 | 11 | -4 | 205,864 | -36.4 % |
| 2023Q4 | 15 | 323,441 |
Institutional managers
64 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BML Capital Management, LLC | 3,167,231 | 10.8M $ | as of Mar 31, 2026 |
| Aquamarine Financial (Cayman) Ltd | 2,112,312 | 7.2M $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 1,910,540 | 6.5M $ | as of Mar 31, 2026 |
| Gem Investment Advisors, LLC | 1,640,069 | 5.6M $ | as of Mar 31, 2026 |
| Murchinson Ltd. | 1,315,294 | 4.5M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 600,716 | 2M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 259,611 | 882.7K $ | as of Mar 31, 2026 |
| Rathbones Group PLC | 233,018 | 792.3K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 158,209 | 537.7K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 157,586 | 535.8K $ | as of Mar 31, 2026 |
| RITHOLTZ WEALTH MANAGEMENT | 155,479 | 528.6K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 147,700 | 502.2K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 146,152 | 496.9K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 136,218 | 463.1K $ | as of Mar 31, 2026 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 116,363 | 395.6K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 98,629 | 335.3K $ | as of Mar 31, 2026 |
| Hillsdale Investment Management Inc. | 97,300 | 330.8K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 92,192 | 313.5K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 52,540 | 178.6K $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 51,670 | 175.7K $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 50,207 | 170.7K $ | as of Mar 31, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 35,313 | 120.1K $ | as of Mar 31, 2026 |
| BAILARD, INC. | 32,478 | 110.4K $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 32,307 | 109.8K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 27,498 | 93 $ | as of Mar 31, 2026 |
Declared shareholders of Oramed Pharmaceuticals Inc
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 5.06 % | 2,047,652 | as of Jan 14, 2026 · SCHEDULE 13G |
| BML Investment Partners, L.P. and 1 other | 2.50 % | 1,026,269 | as of Jun 26, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Oramed Pharmaceuticals Inc". https://titelia.com/en/stocks/oramed-pharmaceuticals-inc-US68403P2039